Posted On: 07 October 2025
The EDEN study (A Randomised-controlled Feasibility Study of Ketamine for the Treatment of Depression with Anorexia Nervosa), led by Consultant Psychiatrist and Reader in Eating Disorders, Dr Hubertus Himmerich, is the first study of its kind investigating the feasibility of oral ketamine vs placebo in people with both anorexia nervosa and major depressive disorder. Dr Himmerich and the EDEN study team, based at the Institute of Psychiatry, Psychology & Neuroscience, explain more about the study, and what it involves as they move into the recruitment phase.